X-47142418-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001135998.3(NDUFB11):c.361G>A(p.Glu121Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001135998.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 131 of the NDUFB11 protein (p.Glu131Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of NDUFB11-related conditions (PMID: 26741492, 31243186, 36252119). In at least one individual the variant was observed to be de novo. This variant is also known as p.E121K. ClinVar contains an entry for this variant (Variation ID: 372149). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects NDUFB11 function (PMID: 26741492). For these reasons, this variant has been classified as Pathogenic. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25772934, 26741492, 31243186, 28050600, 30423443, 27488349, 36675256, 33233646, 31332208) -
Linear skin defects with multiple congenital anomalies 3;C4746985:Mitochondrial complex 1 deficiency, nuclear type 30 Pathogenic:1
- -
Mitochondrial complex 1 deficiency, nuclear type 30 Pathogenic:1
- -
Linear skin defects with multiple congenital anomalies 3 Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with X-linked dominant linear skin defects with multiple congenital anomalies 3 (MIM#300952) and X-linked recessive nuclear type 30 mitochondrial complex I deficiency (MIM#301021). Affected females have been reported with heterozygous null alleles, whereas affected males have only been identified with missense and single residue in-frame deletions, suggesting that some residual enzyme activity is required for males to be viable, whereas complete loss of function variants may be lethal when hemizygous (PMID: 30423443). (I) 0110 - This gene is associated with X-linked disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Affected females have previously been reported to inherit pathogenic variants from their unaffected mothers. It has been suggested that this may be due to patterns of somatic X-chromosome inactivation, mosaicism or additional genetic and external factors (PMID: 28050600). (I) 0115 - Variants in this gene are known to have variable expressivity. Variable syndromic features have been observed in affected individuals. However, anaemia and cardiomyopathy appear to be consistent features in males and females, respectively (PMID: 28050600, PMID: 30423443, PMID: 27488349). (I) 0200 - Variant is predicted to result in a missense amino acid change from glutamic acid to lysine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated ESSS subunit of NADH:ubiquinone oxidoreductase (complex I) (NCBI). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. The variant has previously been classified as pathogenic in ClinVar, and has been reported de novo in a hemizygous male with lethal infantile mitochondrial disorder (PMID: 26741492). Additionally, the variant has been observed in a mother and daughter affected with left ventricular noncompaction (PMID: 31243186); it was not considered to be causative as they did not present with a metabolic disorder, however, the mitochondrial features of NDUFB11-related disease are known to only present in hemizygous males (PMID: 25772934, PMID: 30423443). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Western blots using patient fibroblasts demonstrated no detectable NDUFB11 protein, consistent with a complete loss of function (PMID: 26741492). (SP) 1207 - Parental origin of the variant is unresolved. Testing of this individual's mother did not confirm maternal inheritance. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at